Tepadina (thiotepa) 100 mg: possible risk of defective vials in batches n°1709192/1, n°1709192/2 and n°1709192/3 presenting a crimp seal not properly fixed on the vial
About
This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.
Documents
Key facts
| Medicine name |
Tepadina
|
| Active substance |
thiotepa
|
| Therapeutic area (MeSH) |
Hematopoietic Stem Cell Transplantation
|
| DHPC type |
Quality defect
|
| Human ATC code |
L01AC01
|
| Dissemination date |
01/06/2020
|